Ariza, Celedenio P.
HRN: 24-46-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/25/2024
05/02/2024
IVTT
4.5g
Q6
CAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes